Thyrocare Technologies has announced a final dividend of Rs. 7.00 per equity share for the fiscal year 2025-26, bringing the total dividend to Rs. 9.33 per share post-bonus. The company also unveiled key leadership changes, including the re-appointment of its MD & CEO and new board appointments. Additionally, the Board approved an investment of up to Rs. 5.50 crore in its subsidiary, Think Health Diagnostics, to support its growth and operational expansion.
Financial Highlights and Dividends
The Board of Directors has recommended a final dividend of Rs. 7.00 per equity share for the financial year ended March 31, 2026. Combined with the previously paid interim dividend, the aggregate dividend for the year stands at Rs. 9.33 per share (post-bonus adjustment). This payout remains subject to approval by shareholders at the upcoming Annual General Meeting.
Leadership Transitions
In a significant move to strengthen its executive team, the company announced the re-appointment of Mr. Rahul Franklin Guha as Chairman, Managing Director, and CEO for a five-year term, effective from May 4, 2027, to May 3, 2032. Furthermore, the Board appointed Mr. Uday Patel Kadam and Mr. Gaurav Verma as Additional Directors in the Non-Executive, Non-Independent category, effective May 8, 2026. These appointments coincide with the resignations of Mr. Dharmil Nirupam Sheth and Dr. Dhaval Rajesh Shah, who stepped down from their board positions effective May 7, 2026.
Strategic Investment and Governance
The Board approved an equity infusion of up to Rs. 5.50 crore into its wholly-owned subsidiary, Think Health Diagnostics Private Limited. This investment is designated to support the subsidiary’s operational requirements and capital expenditure. Additionally, the company is undergoing an alteration of its Memorandum of Association to align with the Companies Act, 2013, and to broaden its operational scope, permitting a wider range of activities within the healthcare and diagnostics ecosystem.
Auditor Updates
The company announced the appointment of M/s. Price Waterhouse Chartered Accountants LLP as the new Statutory Auditors for a five-year term, commencing from the conclusion of the 26th Annual General Meeting in 2026. They will succeed the outgoing auditors, M/s. M S K A & Associates LLP. Furthermore, M/s. Jitender Navneet & Co. has been appointed as the Cost Auditor for the financial year 2026-27.
Source: BSE
